Table 5 HLA-DR antigen frequency in healthy control and non-DM individuals with ESRD
|  | Patients (N = 111) | Control (N = 190) |  |  |  |  | ||
|---|---|---|---|---|---|---|---|---|
Antigens | Count | Antigen frequency | Count | Antigen frequency | Odd ratios | 95 % confidence interval (95Â % CI) | P value | Pc value |
DR1 |  |  | 3 | 1.60 % | 0.24 | 0.012–4.694 | NS |  |
DR3 | 28 | 25.20 % | 28 | 14.70 % | 1.95 | 1.085–3.510 | 0.031 | 0.403 |
DR4 | 36 | 32.40 % | 54 | 28.40 % | 1.21 | 0.728–2.008 | NS |  |
DR7 | 8 | 7.20 % | 4 | 2.10 % | 3.61 | 1.062–12.284 | 0.036 | 0.468 |
DR8 | 9 | 8.10 % | 34 | 17.90 % | 0.4 | 0.186–0.880 | 0.026 | 0.338 |
DR9 | 35 | 31.50 % | 56 | 29.50 % | 1.1 | 0.663–1.831 | NS |  |
DR10 | 5 | 4.50 % | 4 | 2.10 % | 2.19 | 0.577–8.346 | NS |  |
DR11 | 24 | 21.60 % | 22 | 11.60 % | 2.11 | 1.118–3.970 | 0.03 | 0.39 |
DR12 | 26 | 23.40 % | 48 | 25.30 % | 0.9 | 0.523–1.565 | NS |  |
DR13 | 5 | 4.50 % | 17 | 8.90 % | 0.48 | 0.172–1.340 | NS |  |
DR14 | 11 | 9.90 % | 25 | 13.20 % | 0.73 | 0.3425–1.539 | NS |  |
DR15 | 17 | 15.30 % | 36 | 18.90 % | 0.77 | 0.412–1.454 | NS |  |
DR16 | 8 | 7.20 % | 25 | 13.20 % | 0.51 | 0.223–1.179 | NS |  |